Skip to main content
S

SD BIOTECHNOLOGIES CO., LTD. — Investor Relations & Filings

Ticker · 217480 ISIN · KR7217480003 KO Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2026-03-24 Declaration of Voting R…
Country KR South Korea
Listing KO 217480

About SD BIOTECHNOLOGIES CO., LTD.

https://snpbeauty.com/

SD BIOTECHNOLOGIES CO., LTD. is a company that engages in the research, development, manufacturing, and sale of cosmetics and skincare products. Operating as a 'Total Skin Solution' provider, it focuses on developing safe and innovative cosmeceutical products based on skin science and rigorous testing. The company's primary brand, SNP, offers a range of solutions grounded in scientific evidence and skincare expertise. Its product portfolio includes basic skincare, mask packs, trouble care products, and healthcare foods, all formulated through extensive research and development to ensure efficacy.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the official announcement of the results of the 2026 annual shareholders’ meeting, detailing vote outcomes, approval of financial statements, director appointments, and resolution vote percentages. This matches the definition of ‘Declaration of Voting Results’ from a general meeting. Therefore, it should be classified as DVA.
2026-03-24 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a Korean “주식 등의 대량보유상황보고서(약식)” (Large Shareholding Report) filed under the Capital Markets Act, showing an institutional investor’s shareholding changes crossing threshold levels. This is precisely a major shareholding notification, not an earnings release, proxy, or management change. Therefore the correct code is MRQ.
2026-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by SD Biotechnologies. It contains the auditor's opinion, key financial data (assets, liabilities, equity, profit/loss), and details regarding capital impairment and operating losses. While it provides financial data, it is a regulatory filing announcing the receipt and submission of the audit report to the exchange, rather than the full 10-K annual report itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2025
2026-03-16 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2025, submitted to the Financial Services Commission and the Korea Exchange. It contains detailed sections on company overview, business operations, financial risk management, and capital structure. As it is a full-year statutory report containing substantive financial data and management analysis, it is classified as an Annual Report (10-K). FY 2025
2026-03-16 Korean
합병등종료보고서(자산양수도)
Regulatory Filings Classification · 1% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of a specific asset transfer (real estate) between SD Biotechnologies and Daewon Pharmaceutical. While the title mentions 'merger', the content explicitly clarifies it is an asset transfer (자산양수도). Since this is a regulatory filing regarding the completion of a corporate transaction (asset disposal) and does not fit into specific categories like M&A (which usually refers to stock-based mergers/acquisitions) or other specialized categories, it is best classified as a Regulatory Filing (RNS).
2026-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for SD Biotechnologies. It outlines the date, time, location, and the agenda items (financial statements, articles of incorporation changes, and director compensation limits) to be voted upon. This document serves as the official notification to shareholders regarding the upcoming meeting, which falls under the category of Proxy Solicitation & Information Statement as it provides the necessary information for shareholders to prepare for the meeting.
2026-03-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.